CLEVELAND, Nov. 21, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer are scheduled to participate in two upcoming investor conferences.
The first conference is the 29th Annual Piper Jaffray Healthcare Conference in New York on November 29, 2017. This conference includes a fireside chat presentation and will allow institutional investors to meet with the Company.
|
Event: |
29th Annual Piper Jaffray Healthcare Conference |
|
Date: |
Wednesday, November 29, 2017 |
|
Time: |
12:00 p.m. ET |
The second conference is the Global Mizuho Investor Conference NY 2017 in New York on December 4, 2017. This conference will allow institutional investors to meet with the Company but does not include a formal presentation.
|
Event: |
Global Mizuho Investor Conference NY 2017 |
|
Date: |
Monday, December 4, 2017 |
An audio webcast of the Company's presentation at the Piper Jaffray conference will be available on the investor relations section of ViewRay's website at www.viewray.com. A replay of the webcast will be available for 14 days after the date of the presentation.
About ViewRay
ViewRay®, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purposely built to deliver high-precision radiation without unnecessary beam distortion, and consequently, help to mitigate skin toxicity and other safety concerns that may otherwise arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
View original content:http://www.prnewswire.com/news-releases/viewray-to-participate-in-upcoming-conferences-300560485.html
SOURCE ViewRay, Inc.
